<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: new antibiotics</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Despite superbug crisis, progress in antibiotic development 'alarmingly elusive'</title>
   	 <description>Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society of America (IDSA) launched its 10 x '20 Initiative in 2010—and that drug was approved two and a half years ago.</description>
     <link>http://medicalxpress.com/news/2013-04-superbug-crisis-antibiotic-alarmingly-elusive.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 18 Apr 2013 00:00:03 EST</pubDate>
	 <guid isPermaLink="false">news285436359</guid>
	 
</item>
<item>
     <title>Key to tuberculosis cure could lie underwater</title>
   	 <description>The search for a cure for deadly infectious diseases has led Brian Murphy deep underwater. Murphy, assistant professor of medicinal chemistry and pharmacognosy at the University of Illinois at Chicago, is collecting actinomycete bacteria from water throughout the world in a hunt for new antibiotics.</description>
     <link>http://medicalxpress.com/news/2013-03-key-tuberculosis-underwater.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 08 Mar 2013 11:43:41 EST</pubDate>
	 <guid isPermaLink="false">news281965413</guid>
	 
</item>
<item>
     <title>Mining for new drugs in the ocean</title>
   	 <description>Each time we use an antibiotic, the weaker strains of infection are killed off while the stronger, more virulent strains are left behind to multiply. In the past, this has not caused much concern, as there has always been a new drug available to fight the infection. Now however, we are running out of options.</description>
     <link>http://medicalxpress.com/news/2013-02-drugs-ocean.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 28 Feb 2013 08:35:44 EST</pubDate>
	 <guid isPermaLink="false">news281262936</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/miningfornew.jpg" width="90" height="90" />
</item>
<item>
     <title>Expert warning: Resistance to antibiotics to be apocalyptic</title>
   	 <description>(Medical Xpress)—The chief medical officer for Britain's Department of Health has issued a warning that resistance to bacteria is a more urgent threat to humanity than global warming, with bacteria becoming resistant to current antibiotics at an alarming rate, and there are almost no new antibiotics in the pipeline.</description>
     <link>http://medicalxpress.com/news/2013-01-expert-resistance-antibiotics-apocalyptic.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 25 Jan 2013 05:20:17 EST</pubDate>
	 <guid isPermaLink="false">news278313610</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/antibiotics.jpg" width="90" height="90" />
</item>
<item>
     <title>Novel approaches needed to end growing scourge of 'superbugs'</title>
   	 <description>With the rising awareness of the so-called &quot;superbugs,&quot; bacteria that are resistant to most known antibiotics, three infectious disease experts writing in the Jan. 24 edition of the New England Journal of Medicine called for novel approaches based on a &quot;reconceptualization of the nature of resistance, disease and prevention.&quot;</description>
     <link>http://medicalxpress.com/news/2013-01-approaches-scourge-superbugs.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 23 Jan 2013 17:30:17 EST</pubDate>
	 <guid isPermaLink="false">news278184610</guid>
	 
</item>
<item>
     <title>BioMAP screening procedure could streamline search for new antibiotics</title>
   	 <description>Researchers at the University of California, Santa Cruz, have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical extracts from natural sources.</description>
     <link>http://medicalxpress.com/news/2012-11-biomap-screening-procedure-antibiotics.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 26 Nov 2012 13:42:13 EST</pubDate>
	 <guid isPermaLink="false">news273159719</guid>
	 
</item>
<item>
     <title>Clinical trials for bacterial meningitis treatments are not keeping pace with the rise of resistance</title>
   	 <description>New vaccines and drug treatments are urgently needed for bacterial meningitis, a devastating disease which kills or maims around a fifth of people who contract it, according to medical experts writing in a new Series on bacterial meningitis, published in The Lancet.</description>
     <link>http://medicalxpress.com/news/2012-11-clinical-trials-bacterial-meningitis-treatments.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 08 Nov 2012 18:30:07 EST</pubDate>
	 <guid isPermaLink="false">news271613751</guid>
	 
</item>
<item>
     <title>Mass spectrometry helps researchers 'watch' how antibiotics attack tuberculosis bacteria inside cells</title>
   	 <description>Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to &quot;see&quot; for the first time exactly how drugs work inside living cells to kill infectious microbes. As a result, scientists may be able to improve existing antibiotics and design new, smarter ones to fight deadly infections, such as tuberculosis. The new study was published in today's early online edition of Science.</description>
     <link>http://medicalxpress.com/news/2012-11-mass-spectrometry-antibiotics-tuberculosis-bacteria.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 01 Nov 2012 14:03:39 EST</pubDate>
	 <guid isPermaLink="false">news270997385</guid>
	 
</item>
<item>
     <title>Apramycin shows promise against drug-resistant TB and other 'superbugs,' without hearing loss</title>
   	 <description>The world needs new antibiotics to overcome the ever increasing resistance of disease-causing bacteria &amp;#150; but it doesn't need the side effect that comes with some of the most powerful ones now available: hearing loss. Today, researchers report they have developed a new approach to designing antibiotics that kill even &quot;superbugs&quot; but spare the delicate sensory cells of the inner ear.</description>
     <link>http://medicalxpress.com/news/2012-06-apramycin-drug-resistant-tb-superbugs-loss.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 11 Jun 2012 15:00:08 EST</pubDate>
	 <guid isPermaLink="false">news258634808</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/killthegerms.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers identify potential target for anthrax drug</title>
   	 <description>(Medical Xpress) -- Researchers at the University of Michigan have identified new targets for drugs that could potentially treat anthrax, the deadly infection caused by Bacillus anthracis.</description>
     <link>http://medicalxpress.com/news/2012-05-potential-anthrax-drug.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 09 May 2012 04:27:34 EST</pubDate>
	 <guid isPermaLink="false">news255756442</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/8-researchersi.jpg" width="90" height="90" />
</item>
<item>
     <title>Infection prevention groups outline steps needed to preserve antibiotics</title>
   	 <description>Infection preventionists and healthcare epidemiologists play key roles in promoting effective antimicrobial stewardship in collaboration with other health professionals, according to a joint position paper published today by the Association for Professionals in Infection Control and Epidemiology (APIC) and the Society for Healthcare Epidemiology of America (SHEA) in their respective peer-review journals, the American Journal of Infection Control and Infection Control and Hospital Epidemiology.</description>
     <link>http://medicalxpress.com/news/2012-03-infection-groups-outline-antibiotics.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 19 Mar 2012 11:44:51 EST</pubDate>
	 <guid isPermaLink="false">news251376282</guid>
	 
</item>
<item>
     <title>DARPA calls for antibiotic replacement</title>
   	 <description>(Medical Xpress) -- Most everyone that has been keeping abreast of world events knows that the clock is ticking on antibiotics; bacteria have been slowly developing a resistance and development of new antibiotics has slowed to a crawl, thus the day will soon come that all of the tools were are currently using to fight bacterial infections will be lost, leaving everyone at their mercy. This problem has not gone unnoticed by those at the upper reaches of the military establishment in the United States, thus it should not come as a surprise to anyone that DARPA, via the Small Business Innovation Research (SBIR) program, has issued a Request for Proposals (RFP) to completely replace antibiotics with something new and better.</description>
     <link>http://medicalxpress.com/news/2011-11-darpa-antibiotic.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 23 Nov 2011 11:17:45 EST</pubDate>
	 <guid isPermaLink="false">news241269449</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/620px-penicillin_core.svg.jpg" width="90" height="90" />
</item>
<item>
     <title>Antibiotic crisis grows while drug companies make lifestyle meds</title>
   	 <description>Antibiotics for acute infections are a pillar of medicine, but doctors say the pillar is crumbling as pharmaceutical companies neglect antibiotic development and instead chase massive profits from chronic illnesses and lifestyle diseases.</description>
     <link>http://medicalxpress.com/news/2011-11-antibiotic-crisis-drug-companies-lifestylemeds.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 22 Nov 2011 10:20:04 EST</pubDate>
	 <guid isPermaLink="false">news241178115</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/antibioticcr.jpg" width="90" height="90" />
</item>
<item>
     <title>Drug-resistant bacteria top agenda of medical convention</title>
   	 <description>The emergence of bacteria resistant to antibiotics and efforts by scientists trying to cope with the problem top the agenda at a medical convention under way here this weekend.</description>
     <link>http://medicalxpress.com/news/2011-09-drug-resistant-bacteria-agenda-medical-convention.html</link>
	 <category>Health</category>
	 <pubDate>Sun, 18 Sep 2011 13:40:27 EST</pubDate>
	 <guid isPermaLink="false">news235572007</guid>
	 
</item>
<item>
     <title>Lifesaving antibiotics face doubtful future</title>
   	 <description>To head off a health care disaster, the Infectious Diseases Society of America (IDSA) has developed a plan to combat deadly antibiotic-resistant &quot;super bugs&quot; and is rolling out the multi-pronged plan today, on World Health Day 2011.</description>
     <link>http://medicalxpress.com/news/2011-04-lifesaving-antibiotics-future.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 07 Apr 2011 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news221393826</guid>
	 
</item>


</channel>
</rss>
